CD30 lymphomatoid skin toxicity secondary to ipilimumab.

JAAD Case Rep

Department of Pathology and Dermatology, MD Anderson of Houston, Houston, Texas.

Published: April 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082605PMC
http://dx.doi.org/10.1016/j.jdcr.2016.07.008DOI Listing

Publication Analysis

Top Keywords

cd30 lymphomatoid
4
lymphomatoid skin
4
skin toxicity
4
toxicity secondary
4
secondary ipilimumab
4
cd30
1
skin
1
toxicity
1
secondary
1
ipilimumab
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!